Liens rapides
Catégories
Fiches d'information
Les fiches d'information fournissent des informations supplémentaires sur l'industrie mondiale des protéines plasmatiques thérapeutiques.
Publications et présentations
Discover the main highlights of our industry in our latest publications.
Ressources pour les patients
Explorez les ressources de PPTA pour les patients intéressés par les thérapies aux protéines plasmatiques.
Rapports des parties prenantes
Apprenez-en plus en accédant à la collection de rapports de l'industrie.
Actualités et communiqués de presse
Restez au courant de l'actualité et des événements de l'Association.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Jan 20, 2015
Ensuring Access to Medicines for Patients
(20th January 2015 – Brussels) – AESGP, EFPIA, EGA, and PPTA are pleased to announce today’s release of the joint principles for “Communication of information on quality and manufacturing potential supply disruption”.
All
Press releases
Jan 20, 2015
Ensuring Access to Medicines for Patients
(20th January 2015 – Brussels) – AESGP, EFPIA, EGA, and PPTA are pleased to announce today’s release of the joint principles for “Communication of information on quality and manufacturing potential supply disruption”.
All
Press releases
Dec 2, 2014
PPTA Statement on MSM Donor Policy
The Plasma Protein Therapeutics Association (PPTA) is the international trade association and standards-setting organization for the world’s major producers of plasma-derived and recombinant analog therapies, collectively referred to as plasma protein therapies.
All
PPTA statements
Dec 2, 2014
PPTA Statement on MSM Donor Policy
The Plasma Protein Therapeutics Association (PPTA) is the international trade association and standards-setting organization for the world’s major producers of plasma-derived and recombinant analog therapies, collectively referred to as plasma protein therapies.
All
PPTA statements
Dec 1, 2014
The Source Winter 2014
Magazine of the plasma protein therapeutics industry - Winter 2014
All
The Source Magazine
https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/644fcd50395a6eb51ca4ada8_Source_Winter%202014.pdf
Dec 1, 2014
The Source Winter 2014
Magazine of the plasma protein therapeutics industry - Winter 2014
All
The Source Magazine
https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/644fcd50395a6eb51ca4ada8_Source_Winter%202014.pdf
Oct 13, 2014
Ebola Virus and Plasma Protein Therapies
During the October, 21 2016, Source Board of Directors meeting, the Board agreed to remove the voluntary deferral for 60 days of donors returning from Ebola virus disease affected areas in the previous 60 days. The deferral was originally implemented on or about October 13, 2014.
All
PPTA statements
Oct 13, 2014
Ebola Virus and Plasma Protein Therapies
During the October, 21 2016, Source Board of Directors meeting, the Board agreed to remove the voluntary deferral for 60 days of donors returning from Ebola virus disease affected areas in the previous 60 days. The deferral was originally implemented on or about October 13, 2014.
All
PPTA statements
Aucun résultat n'a été trouvé